Keith S. Manchester, Director at Roivant Sciences Ltd. (ROIV), sold 13,792,288 shares at $11.55 ($159.3M) on 2023-09-28, disclosed to the SEC on 2023-10-02.
Open-market sale of $159.3M ROIV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.55 | 446,394 | $5.2M | 3.2% |
| 2 | $11.55 | 446,394 | $5.2M | 3.2% |
| 3 | $11.55 | 1,104,599 | $12.8M | 8.0% |
| 4 | $11.55 | 1,104,599 | $12.8M | 8.0% |
| 5 | $11.55 | 2,285,783 | $26.4M | 16.6% |
| 6 | $11.55 | 2,285,783 |
| $26.4M |
| 16.6% |
| 7 | $11.55 | 3,059,368 | $35.3M | 22.2% |
| 8 | $11.55 | 3,059,368 | $35.3M | 22.2% |
| Total | $11.55 avg | 13,792,288 | $159.3M | 100% |
| Filing → |
| ROIV | SELL | 2025-12-18 | $71.8M | — | Filing → |
| ROIV | SELL | 2025-11-21 | $29.8M | — | Filing → |
| ROIV | SELL | 2024-09-26 | $11.7M | — | Filing → |